Details for New Drug Application (NDA): 019421
✉ Email this page to a colleague
NDA 019421 describes EXIDINE, which is a drug marketed by Xttrium and is included in four NDAs. It is available from twenty-three suppliers. Additional details are available on the EXIDINE profile page.
The generic ingredient in EXIDINE is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
The generic ingredient in EXIDINE is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
Summary for 019421
| Tradename: | EXIDINE |
| Applicant: | Xttrium |
| Ingredient: | chlorhexidine gluconate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019421
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 2.5% | ||||
| Approval Date: | Dec 17, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
